Phase 1 Glioblastomas Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Brain CancerGBMGlioma+12 more

National Institute of Neurological Disorders and Stroke (NINDS)40 enrolled1 locationNCT07416188

Recruiting

Phase 1

BC008-1A Injection for Recurrent CNS WHO G4 Glioma

GliomaGlioblastoma WHO Grade IVGlioma Tumor Recurrence+2 more

Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.40 enrolled1 locationNCT06773481